HOME >> BIOLOGY >> NEWS
Unified physics theory explains animals' running, flying and swimming

e. "It doesn't matter whether the animal has eight legs, four legs, two, even if it swims with no legs."

First conceived by Bejan and published in 1996, the constructal law arises from the basic principle that flow systems evolve so as to minimize imperfections -- energy wasted to friction or other forms of resistance -- such that the least amount of useful energy is lost.

The theory applies to virtually everything that moves, Bejan said. For example, his earlier work has examined how the law explains traffic flows, the cooling of small-scale electronics and river currents.

The researchers, funded by the National Science Foundation, report that the constructal law predicts universal relationships between animals' body mass and speed, as well as the frequency and force of the strides, beats or undulations that propel their bodies forward.

"Running, swimming and flying occur in vastly different physical environments and, likewise, involve quite different body mechanics," Bejan said of the new application of constructal law. "Nonetheless, there are strong convergences in certain functional characteristics of runners, swimmers and fliers."

For example, the stride frequency of running vertebrates bears the same relationship to the animals' mass as does the rate at which fish swim. Similarly, the velocity of runners conforms to the same principles as the speed of birds in flight.

The force generated by the muscular "motors" of runners, swimmers and fliers also conforms with surprisingly little variation to a universal value dependent only on muscle mass, Marden said. Why this relationship should be so had remained mysterious, he said.

In the absence of a unifying theory for such design features, biologists had looked to mechanical constraints for an answer, the researchers said. Many authors have suggested that effects of scale in locomotion stem from biomechanical safety factors: the need to avoid premature failu
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-660-8414
Duke University
30-Dec-2005


Page: 1 2 3 4 5

Related biology news :

1. Unraveling the physics of DNAs double helix
2. Pendulum love, science class gender gaps, musical mind mirrors, and unparticle physics
3. Manchester to spearhead 8.3 million particle physics project
4. Press conferences at the years largest physics meeting
5. Largest physics meeting of the year, in Denver
6. Protein folding physics, nanohandles, sunscreen for algae and classical quantum weirdness
7. Technique used commonly in physics finds application in neuroscience
8. What do Racquel Welch and quantum physics have in common?
9. APS physics tip sheet #62
10. Biggest physics meeting of the year
11. APS physics tip sheet #57

Post Your Comments:
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
(Date:4/16/2015)... Morton Grove, IL (PRWEB) April 16, 2015 ... the American Association for Cancer Research (AACR) ... at the Pennsylvania Convention Center, starting Saturday, April 18, ... The AACR holds claim to title of the oldest ... several journals, provides fellowships and grants, and partners with ...
(Date:4/16/2015)... The Council for Agricultural Science and ... CAST Communication Award goes to Dr. Channapatna Prakash, ... Alabama. Award nominees must demonstrate an ability to ... use of television, radio, or other social media. ... specialist in the field of plant genetics and ...
(Date:4/16/2015)... Md. , April 16, 2015  RegeneRx ... today announced its U.S. joint venture with G-treeBNT ... a phase 3 clinical trial for the orphan ... confirmatory trial for dry eye syndrome (DES) in ... preservative-free eye drops, RGN-259/GBT201, this year.  Each of ...
(Date:4/16/2015)... A new infographic compiles useful information ... institutions to learn how Appleā€™s new framework can change ... is ideal since Apple made Research Kit ... open-source framework for developing medical research apps that Apple ... researchers to collect secure clinical data and communicate via ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2The 2015 Borlaug CAST Communication Award Goes to Channapatna Prakash 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3
Cached News: